Tehran (IP)- The production line of "Remdesivir" to treat coronavirus inaugurated with the presence of the head of the Actover pharmaceutical company Nahaleh Naraqi.

Iran Press/Iran News: "Remdesivir" is similar in quality to a foreign drug and is produced in the country at a much lower price than foreign samples. The efficacy of Remdesivir has been confirmed in patients with hypoxia and is not recommended for all patients with coronavirus.

Earlier, Iran's Minister of Health Saeed Namaki reported the progress of several Iranian research teams in the production of a COVID-19 vaccine, expressing hope that people will hear good news in this regard.

Namaki said that the Iranian-made vaccine worked on animals and yielded good results and will be soon tested on humans too.


Read More:

First Iranian corona medicine to present soon: President says

US inhumane sanctions, obstacle in supplying medicine for chemical victims

'Sanctions on transportation of medicine, medical equipment to Iran, contrary to US claims'